Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
30 hedge funds and large institutions have $15.1M invested in Fibrocell Science Inc. in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 9 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less capital invested
Capital invested by funds: $17.9M → $15.1M (-$2.82M)
19% less funds holding
Funds holding: 37 → 30 (-7)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$102K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$37.6K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$19.2K |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$7.87K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
-$335K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$104K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$99.1K |
| 4 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
-$71.5K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$61K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $2K | +$204 | +19 | +10% |
|
27
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1K | – | – | – |
|
28
BNP Paribas Financial Markets
Paris,
France
| $3 | – | – | – |
|
|
QF
29
QVT Financial
New York
| – | -$335K | -31,045 | Closed |
|
|
OAM
30
Oxford Asset Management
Oxford,
United Kingdom
| – | -$104K | -9,668 | Closed |
|
|
31
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$61K | -5,629 | Closed |
|
|
SIP
32
Stoneridge Investment Partners
Radnor,
Pennsylvania
| – | -$31K | -2,872 | Closed |
|
|
MLM
33
Mount Lucas Management
Newtown,
Pennsylvania
| – | -$18K | -1,667 | Closed |
|
34
New York State Common Retirement Fund
Albany,
New York
| – | -$15K | -1,389 | Closed |
|
35
UBS Group
Zurich,
Switzerland
| – | -$4K | -400 | Closed |
|
|
JFA
36
JNBA Financial Advisors
Bloomington,
Minnesota
| – | -$1K | -133 | Closed |
|
|
S
37
SignatureFD
Atlanta,
Georgia
| – | -$1K | -133 | Closed |
|
|
TWA
38
TCI Wealth Advisors
Tucson,
Arizona
| – | -$150 | -14 | -30% |
|
FCSC Hedge Fund Activity: Q4 2016 in Review
30 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q4 2016, worth a combined $15.1M — down 16% from $17.9M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of FCSC and 2 opened new positions — a net loss of 7 holders — while 9 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, adding an estimated $102K. The largest seller was QVT Financial, exiting entirely with an estimated $335K sold.
- 30 institutional investors held Fibrocell Science Inc. (FCSC) as of Q4 2016, down from 37 in Q3 2016.
- Funds reported $15.1M of Fibrocell Science Inc. stock for Q4 2016, down 16% quarter-over-quarter.
- 2 funds opened new Fibrocell Science Inc. positions in Q4 2016 and 9 closed out, a net change of -7 holders.
- The largest Fibrocell Science Inc. buyer in Q4 2016 was Renaissance Technologies, an estimated $102K added.
- The largest Fibrocell Science Inc. seller in Q4 2016 was QVT Financial, an estimated $335K sold.
Based on aggregated 13F filings for Q4 2016.